97 studies found for:    Open Studies | "Dry Eye Syndromes"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Dry Eye Syndromes" (97 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Conditions: Dry Eye Syndromes;   Keratoconjunctivitis Sicca
Intervention: Drug: KPI-121
2 Not yet recruiting Pilot Study to Clinical Evaluate Device Prototypes in Dry Eye Patients
Condition: Dry Eye Syndrome
Intervention: Device: Lacrima medical Prototypes
3 Recruiting Effects of Conventional Dry Eye Treatments on the Ocular Surface Response to Low Humidity Environment in Patients With Keratoconjunctivitis Sicca
Conditions: Keratoconjunctivitis Sicca;   Dry Eye Syndrome
Intervention: Drug: dexamethasone, artificial tears
4 Unknown  Treatment of Dry Eye With Supplements
Condition: Dry Eye Syndromes
Intervention: Dietary Supplement: Vitamac® Tag and Nacht capsules
5 Recruiting Efficacy and Safety Study of Haporine-S for Treatment of Moderate to Severe Dry Eye Syndromes
Condition: Dry Eye Syndromes
Interventions: Drug: Haporine-S;   Drug: Restasis (cyclosporine 0.05%)
6 Unknown  Pilot Study of a Homeopathic Therapy in Combination With Cyclosporin (Restasis) in the Treatment of Dry Eye Disease
Condition: Dry Eye Syndromes
Interventions: Drug: euphrasia based homeopathic therapy and cyclosporin;   Drug: cyclosporin solution
7 Recruiting Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease
Conditions: Primary Sjogren Syndrome;   Secondary Sjogren Syndrome;   Aqueous Deficient Dry Eye Disease;   Evaporative Dry Eye Disease
Interventions: Drug: Restasis;   Drug: Refresh Endura
8 Recruiting Safety and Efficacy of rhNGF Eye Drops at Different Doses in Patients With Dry Eye
Condition: Dry Eye Syndrome.
Interventions: Biological: Human nerve growth factor 20 µg/mL;   Biological: Human nerve growth factor 4 µg/mL or 60 µg/mL
9 Unknown  Altaire Gel Forming Solution Versus Refresh Tears for the Treatment of Dry Eye Signs and Symptoms
Condition: Dry Eye Syndromes
Interventions: Drug: Altaire Gel forming solution;   Drug: Refresh Tears
10 Recruiting Efficacy of Pulsed Light Therapy for Meibomian Gland Dysfunction and Dry Eye Syndrome
Conditions: Meibomian Gland Dysfunction;   Dry Eye Syndrome
Interventions: Device: Cutera Xeo Platform-Limelight;   Device: Sciton BroadBand Light
11 Recruiting Efficacy and Safety of T2762 and Vismed® in Dry Eye Syndrome
Condition: Dry Eye Syndrome
Interventions: Device: T2762;   Device: Vismed®
12 Unknown  A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty Acid Supplement and Its Effect on Patients With Apparent Aqueous Deficient Dry Eye Syndrome
Condition: Dry Eye Syndrome
Intervention: Drug: Essential fatty acid supplement
13 Recruiting Efficacy and Safety of Fluorometholone (FML) in Dry Eye Disease (Keratoconjunctivitis Sicca)
Condition: Dry Eye
Interventions: Drug: FML 0.1% eyedrops;   Drug: Liquifilm artificial tears eyedrops
14 Recruiting Civamide Nasal Solution for Dry Eye
Condition: Dry Eye
Intervention: Drug: Civamide Nasal Spray
15 Not yet recruiting Topical Steroid Treatment For Dry Eye
Condition: Dry Eye
Intervention: Drug: Loteprednol Etabonate (FML)
16 Recruiting A Study to Determine the Relief of Dry Eye Symptoms With the Use of TheraTears® Products (DUNLIN)
Condition: Dry Eye Syndromes
Interventions: Drug: TheraTears® Lubricant Eye Drop;   Drug: TheraTears® preservative-free single-use containers;   Dietary Supplement: TheraTears® Nutrition;   Other: TheraTears® TheraLid® Eyelid Cleanser
17 Recruiting Effect of Contact Lens With Alginic Acid in Dry Eye Patients
Condition: Dry Eyes
Interventions: Device: Contact Lens with alginic acid;   Device: Contact Lens without alginic acid
18 Recruiting DNase Treatment for Dry Eyes
Condition: Dry Eye
Interventions: Drug: DNase;   Drug: Vehicle
19 Not yet recruiting Assessment of Tear Film Thickness by Optical Coherence Tomography in Healthy Subjects and Subjects With Dry Eye Disease
Condition: Dry Eye Syndrome
Interventions: Device: GENTEAL HA® Eye Drops (NOVARTIS, Switzerland);   Other: Physiological Sodium Chloride solution (0,9%)
20 Recruiting Clinical Outcomes Following Treatment With Systane® Balance in Dry Eye Subjects
Condition: Dry Eye
Interventions: Drug: Propylene Glycol, 0.6% eye drops;   Drug: Preservative-free 0.9% Saline solution

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years